PhD candidate
Research interests
Te Whetu Aarahi Kerekere is a PhD candidate studying Mendelian cardiovascular inherited disease genetics, with a focus on whānau Māori, under the supervision of Professor Martin Kennedy.
Publications
Hitchman, L., Kerekere, T. W. A., Miller, A. L., Goodin, E., Koia, C., Watson, H., … Robertson, S. P., Wilcox, P., & Kennedy, M. A. (2026). Allelic diversity of the pharmacogenes CYP2D6 and CYP2C19 in Māori from Te Tairāwhiti, Aotearoa New Zealand. Frontiers in Genetics, 17, 1668409. doi: 10.3389/fgene.2026.1668409 Journal - Research Other
Hogan, S., Stiles, R., Kerr, R., Burcher, S., Kerekere, T. W., Agnew, J., … Le Quesne Stabej, P. (2025). Our heart, our genes, our story: Ō tātou ngākau, ō tātou ira, ō tātou kōrero. Heart, Lung & Circulation, 34(Suppl. 3), O16. doi: 10.1016/j.hlc.2025.05.016 Conference Contribution - Published proceedings: Abstract
Kerekere, T. W. A., Hitchman, L., Miller, A. L., Goodin, E., Koia, C., Watson, H., Robertson, S. P., Wilcox, P., & Kennedy, M. A. (2024). Allelic diversity of pharmacogenes CYP2D6 and CPY2C19 in Māori from Te Tairāwhiti, Aotearoa New Zealand. Proceedings of the 17th GeneMappers Conference. Retrieved from https://www.genemappersconference.org Conference Contribution - Published proceedings: Abstract
Kerekere, T. W., Hitchman, L., Miller, A. L., Wilcox, P., Robertson, S., Watson, H., & Kennedy, M. A. (2023, August). Nanopore sequencing of the pharmacogene CYP2C19 in a Ngāti Porou Hauora cohort. Verbal presentation at the Queenstown Molecular Biology (QMB) Genomics Satellite, Queenstown, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs